{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:57:42Z","timestamp":1781308662648,"version":"3.54.1"},"reference-count":21,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2008,5,29]],"date-time":"2008-05-29T00:00:00Z","timestamp":1212019200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2008,9]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold>The use of granulocyte\u2013colony\u2010stimulating factor (G\u2010CSF) for mobilization, collection, and transplantation of autologous hematopoietic progenitor cells (HPCs) in patients with hemoglobinopathies can be complicated by severe vasoocclusive crises. Erythrocytapheresis before G\u2010CSF administration may help prevent these complications. To date, no cases regarding the safety and outcome of erythrocytapheresis followed by autologous high\u2010dose G\u2010CSF mobilization in hemoglobinopathy populations have been reported.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold>A patient with hemoglobin (Hb) SC disease and multiple myeloma underwent erythrocytapheresis followed by high\u2010dose (16\u2003\u00b5g\/kg) G\u2010CSF in preparation for HPC mobilization and collection.<\/jats:p><jats:p><jats:bold>RESULTS:<\/jats:bold>Erythrocytapheresis reduced the patient's combined Hb\u2003S and C levels to less than 20 percent. Subsequent HPC mobilization and peripheral blood harvesting using high\u2010dose G\u2010CSF yielded approximately 9\u2003\u00d7\u200310<jats:sup>6<\/jats:sup>CD34+ HPCs per kg over 3 days of collection. Mobilization and leukapheresis were completed without vasoocclusive complications. Two weeks after collection, and after myeloablative chemotherapy, 5.33\u2003\u00d7\u200310<jats:sup>6<\/jats:sup>CD34+ HPCs per kg were infused to the patient; platelet and white cell engraftment occurred, respectively, on Days\u2003+9 and +10 posttransplant. The patient experienced no vasoocclusive complications in the posttransplant period.<\/jats:p><jats:p><jats:bold>CONCLUSIONS:<\/jats:bold>The results of this case demonstrate that erythrocytapheresis before high\u2010dose G\u2010CSF HPC mobilization and collection appears to be an effective means for prevention of vasoocclusive crisis in patients with hemoglobinopathies undergoing autologous stem cell transplantation.<\/jats:p>","DOI":"10.1111\/j.1537-2995.2008.01777.x","type":"journal-article","created":{"date-parts":[[2008,5,29]],"date-time":"2008-05-29T13:22:27Z","timestamp":1212067347000},"page":"1930-1933","source":"Crossref","is-referenced-by-count":7,"title":["Mobilization, collection, and transplantation of peripheral blood hematopoietic progenitor cells in a patient with multiple myeloma and hemoglobin SC disease"],"prefix":"10.1111","volume":"48","author":[{"given":"Christopher A.","family":"Tormey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward L.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis L.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,9]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.moh.0000182836.40779.e7"},{"key":"e_1_2_4_3_2","first-page":"46","article-title":"The current status of hematopoietic stem cell transplantation for multiple myeloma","volume":"2","author":"Bensinger W","year":"2004","journal-title":"Clin Adv Hematol Oncol"},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2007.08.002"},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.3.850"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)60614-9"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.12.3998"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.10.3313"},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705376"},{"key":"e_1_2_4_10_2","first-page":"1187","article-title":"Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine","volume":"89","author":"Borgna\u2010Pignatti C","year":"2004","journal-title":"Haematologica"},{"key":"e_1_2_4_11_2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0065-3101(23)00100-7","article-title":"Major changes in sickle cell disease","volume":"47","author":"Hagar R","year":"2000","journal-title":"Adv Pediatr"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199406093302303"},{"key":"e_1_2_4_13_2","doi-asserted-by":"publisher","DOI":"10.1080\/1042819022386833"},{"key":"e_1_2_4_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830210212"},{"key":"e_1_2_4_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/jca.20112"},{"key":"e_1_2_4_16_2","volume-title":"Transfusion support for patients with sickle cell D","author":"Rosse W","year":"1998"},{"key":"e_1_2_4_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.1.266"},{"key":"e_1_2_4_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2007.00926.x"},{"key":"e_1_2_4_19_2","doi-asserted-by":"publisher","DOI":"10.1159\/000083451"},{"key":"e_1_2_4_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-007-0286-6"},{"key":"e_1_2_4_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2005.04222.x"},{"key":"e_1_2_4_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705848"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1537-2995.2008.01777.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1537-2995.2008.01777.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T20:49:40Z","timestamp":1708980580000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1537-2995.2008.01777.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["10.1111\/j.1537-2995.2008.01777.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1537-2995.2008.01777.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}